Bionomics Limited

ASX:BNO Rapporto sulle azioni

Cap. di mercato: AU$14.7m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Bionomics Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Spyros Papapetropoulos

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOless than a year
Proprietà del CEOn/a
Durata media del managementless than a year
Durata media del Consiglio di amministrazione3yrs

Aggiornamenti recenti sulla gestione

Recent updates

Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?

Jun 14
Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?

Is Bionomics (ASX:BNO) In A Good Position To Invest In Growth?

Feb 23
Is Bionomics (ASX:BNO) In A Good Position To Invest In Growth?

Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?

Sep 14
Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?

Companies Like Bionomics (ASX:BNO) Are In A Position To Invest In Growth

Nov 15
Companies Like Bionomics (ASX:BNO) Are In A Position To Invest In Growth

Did You Miss Bionomics' (ASX:BNO) 86% Share Price Gain?

Dec 30
Did You Miss Bionomics' (ASX:BNO) 86% Share Price Gain?

AMMINISTRATORE DELEGATO

Spyros Papapetropoulos (50 yo)

less than a year

Mandato

Dr. Spyridon Papapetropoulos, M. D., Ph. D., also known as Spyros, serves as Director, President & Chief Executive Officer at Bionomics Limited from January 05, 2023. He serves as Member of Scientific Advi...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Adrian Hinton
Financial Controllerless than a yearAU$323.78k0.0048%
A$ 700.6
Spyridon Papapetropoulos
CEO, President & Directorless than a yearNessun datoNessun dato
Timothy Cunningham
Chief Financial Officerless than a yearNessun datoNessun dato
Paul Rolan
Consultant Chief Medical Officer of Clinical Neuroscienceno dataAU$102.00kNessun dato
Julie Kerner
Senior Vice President of Business Operationsless than a yearNessun datoNessun dato
Atul Mahableshwarkar
Acting Chief Medical Officerless than a yearNessun datoNessun dato
Suzanne Irwin
Company Secretary2.3yrsNessun datoNessun dato

0.3yrs

Durata media

60yo

Età media

Gestione esperta: Il team dirigenziale di BNO non è considerato esperto (durata media 0.3 anni), il che suggerisce un nuovo team.

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Spyridon Papapetropoulos
CEO, President & Directorless than a yearNessun datoNessun dato
Errol B. De Souza
Non-Executive Director15.5yrsAU$4.03m0.025%
A$ 3.7k
David Wilson
Independent Non-Executive Director7.2yrsAU$87.00k0.017%
A$ 2.5k
Alan Fisher
Independent Non-Executive Chair of the Board6.9yrsAU$87.00k0.0068%
A$ 1.0k
Jane Ryan
Independent Non-Executive Director2.8yrsAU$93.15k0%
A$ 0
Srinivas Rao
Member of Clinical Advisory Board1.8yrsAU$57.75kNessun dato
Murray Stein
Member of Clinical Advisory Boardno dataNessun datoNessun dato
Steven Williams
Scientific Advisorno dataNessun datoNessun dato
Allan Young
Scientific Advisorno dataNessun datoNessun dato
Marina Picciotto
Scientific Advisorno dataNessun datoNessun dato
Peter Miles Davies
Independent Non-Executive Director2.1yrsAU$77.00k0.018%
A$ 2.7k
Aaron N. Weaver
Independent Non-Executive Nominee Director3.1yrsAU$77.00kNessun dato

3.0yrs

Durata media

56.5yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di BNO non è considerato esperto (durata media del mandato 3 anni), il che suggerisce un nuovo consiglio.